Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References

  1. ^ Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, et al. (July 1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.
Allikas: https://en.wikipedia.org/wiki/Regavirumab
No tags for this post.